|
[1]
|
World Health Organization. Coronavirus disease (COVID-19) situation reports. 2022. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. [2022-3-12].https://www.who.int/emergencies/diseases/novel-coronavirus-2019 |
|
[2]
|
Feng S, Phillips DJ, White T, Sayal H, Aley PK, Bibi S, et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med 2021;27(11):2032 − 40. http://dx.doi.org/10.1038/s41591-021-01540-1CrossRef
|
|
[3]
|
Zhang M, Xiao JP, Deng AP, Zhang YT, Zhuang YL, Hu T, et al. Transmission dynamics of an outbreak of the COVID-19 delta variant B.1.617.2 - Guangdong province, China, May-June 2021. China CDC Wkly, 2021;3(27):584-6. http://dx.doi.org/10.46234/ccdcw2021.148.http://dx.doi.org/10.46234/ccdcw2021.148 |
|
[4]
|
Liu SW, Yuan SH, Sun YQ, Zhang BG, Wang HZ, Lu JX, et al. A COVID-19 outbreak - Nangong city, Hebei province, China, January 2021. China CDC Wkly 2021;3(19):401 − 4. http://dx.doi.org/10.46234/ccdcw2021.077CrossRef
|
|
[5]
|
Hou L, Zhou H, Meng NX, Yu X, Wang X, Wang T, et al. A COVID-19 outbreak emerging in a food processing company — Harbin city, Heilongjiang province, China, January–February 2021. China CDC Wkly 2021;3(32):681 − 7. http://dx.doi.org/10.46234/ccdcw2021.153CrossRef
|
|
[6]
|
Li ZJ, Guan XH, Mao NY, Luo HM, Qin Y, He N, et al. Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China. Lancet Reg Health West Pac 2021;8:100094. http://dx.doi.org/10.1016/j.lanwpc.2021.100094CrossRef
|
|
[7]
|
Perry KR, Brown DWG, Parry JV, Panday S, Pipkin C, Richards A. Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol 1993;40(3):235 − 40. http://dx.doi.org/10.1002/jmv.1890400312CrossRef
|
|
[8]
|
Huang Q, Liu FY, Mao NY, Sun JY, Dong M, Xie H, et al. Application of oral fluid in SARS-CoV-2 nucleic acid and antibody detection. Chin J Prev Med 2022;56(3):355 − 9. http://dx.doi.org/10.3760/cma.j.cn112150-20211211-01146 (In Chinese). CrossRef
|
|
[9]
|
Hoschler K, Ijaz S, Andrews N, Ho S, Dicks S, Jegatheesan K, et al. SARS antibody testing in children: development of oral fluid assays for IgG measurements. Microbiol Spectr 2022;10(1):e0078621. http://dx.doi.org/10.1128/spectrum.00786-21CrossRef
|
|
[10]
|
Heaney CD, Pisanic N, Randad PR, Kruczynski K, Howard T, Zhu XM, et al. Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers. medRxiv Preprint. http://dx.doi.org/10.1101/2021.01.28.21250717.http://dx.doi.org/10.1101/2021.01.28.21250717 |
|
[11]
|
George JR, Fitchen JH. Future applications of oral fluid specimen technology. Am J Med 1997;102(4A):21 − 5. http://dx.doi.org/10.1016/s0002-9343(97)00034-xCrossRef
|